GlassScriptPhysician profile
Vincent Varghese
NPI 1316145808
$18,345.57
in general payments reported to CMS, 2019-2025
25 companies · $4,341 in 2025
The $4,341 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,705 · 2020: $380 · 2021: $916 · 2022: $3,509 · 2023: $1,880 · 2024: $3,615 · 2025: $4,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,035 · Consulting Fee: $2,600 · Travel and Lodging: $1,643 · Long Term Medical Supply Or Device Loan: $958 · Honoraria: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,034.52 |
| Consulting Fee | $2,600.00 |
| Travel and Lodging | $1,643.11 |
| Long Term Medical Supply Or Device Loan | $958.34 |
| Honoraria | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,588.53 | 2019-2025 | Jot Dx, Diamondback Peripheral |
| Medtronic, INC. | $2,583.44 | 2021-2025 | Symplicity G3, Onyx Frontier, Ellipsys Vascular Access System |
| Cagent Vascular INC | $2,154.12 | 2022-2023 | Serrantor |
| Siemens Medical Solutions USA, INC. | $1,950.07 | 2020-2024 | Acuson Sc2000 Diagnostic Ultrasound System |
| Terumo Medical Corporation | $1,600.00 | 2024-2025 | Navicross |
| Boston Scientific Corporation | $1,583.39 | 2019-2025 | Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit, Watchman Access System |
| Angiodynamics, INC. | $1,464.94 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Philips North America LLC | $1,009.25 | 2019-2025 | (6554) Periph Vasc Undiv, Peripheral Vascular Undivided |
| Infraredx, INC. | $1,000.00 | 2025 | |
| Abiomed | $357.30 | 2019-2024 | Impella |
| Medtronic Vascular, INC. | $348.02 | 2019 | |
| Inari Medical, INC. | $272.72 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $229.72 | 2019 | |
| Cardiovascular Systems INC. | $208.22 | 2019-2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $176.36 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $157.15 | 2019 | |
| Biotronik INC. | $150.52 | 2021-2022 | |
| Edwards Lifesciences Corporation | $115.15 | 2019 | |
| Avinger INC. | $109.14 | 2019 | |
| Asahi Intecc USA, INC. | $76.90 | 2025 | Asahi Interventional Radiology Wires |
| Teleflex LLC | $73.56 | 2023-2024 | Guideliner, Turnpike |
| Cardiac Dimensions, INC. | $61.23 | 2022 | |
| Reflow Medical INC | $45.93 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $15.01 | 2024 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $14.90 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,087.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Varghese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.